Ying Liu

Help prevent “missed opportunities” in #ovariancancer @saramoufarrij1 found 15-23% of patients w/ HGSOC had a surgery where opportunistic salpingectomy (OS) was missed. @KaraLongRoche & others are raising awareness. We need data to guide patients! @TeamOvary_MSK @MSKCancerCenter

In 2024, led by our immediate past president Bryson Katona, MD, PhD, the #CGAIGC Executive Council developed a 3-year strategic plan to guide our society's future ➡️We’re proud to share this roadmap as we mark #CGAIGC’s 30th anniversary and its publication in FamilialCancer!…

So proud of @saramoufarrij1 who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! @TeamEndo_MSK @TeamOvary_MSK @MSKCancerCenter @MSK_DeptOfMed

Promising combo of Pembro + Olaparib in p53 aberrant/CN-H #endometrialcancer presented by @MariaRubinstein at #ASCO25! We need more biomarkers to find those long term responders. @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed

Congratulations to Kenneth Offit, MD, MPH of @MSKCancerCenter in being the Giants of Cancer Care Prevention/Genetics inductee! #GiantsCC25

Read more about research from @AliciaLatham10 aimed to investigate the potential of Pap-derived #ctDNA (Pap-ctDNA) as a novel noninvasive tool for EC detection from @ASCO. #ASCO25

Check out @ariadnaroque8 and her awesome #ASCO25 poster building on work from @TeamOvary_MSK looking at #breastcancer after #ovariancancer in this with germline mutations in non-BRCA HR genes, shockingly none! @MSKCancerCenter @MSK_DeptOfMed

So proud of @WeillCornell resident #judywang for her hard work characterizing the germline landscape of early-onset #endometrialcancer! It is unique and needs attention #ASCO25 @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed @MSKCancerCenter

We were so fortunate to have a fantastic discussion with world-renowned expert Dr. Pei Hui MD PhD regarding diagnosis and management of gestational trophoblastic neoplasia as part of our departmental lecture series program. @TeamOvary_MSK @TeamEndo_MSK

🚨The FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade serous #ovariancancer. Congrats to MSK's Rachel Grisham, Global Lead Principal Investigator of GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301! bit.ly/3ETZS2F

Congrats to Mark G. Kris, Kenneth Offit, David G. Pfister, and @szusmani on being inducted into the 13th Giants of Cancer Care® class by @OncLive! This award honors leading physicians who are advancing #cancerresearch. @MSKCancerCenter Learn more: bit.ly/42Ox58M

Although we will miss her @MSKCancerCenter and in our GMO group, there are only congratulations for @ClaireFriedma19 as she embarks on the next phase of her career! @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed

Please join us for @MSKCancerCenter’s 14th Annual Lynch Syndrome Educational Workshop 🗓️ Tues, May 6 ⌚️6-8:30 PM 📍Zoom Register: bit.ly/3EsxdBp @CGAIGC @FightCRC @Alive_And_Kickn @GlobalCRC @CCAlliance @ColonCancerFdn @ColonCancerCoal @insightmeeting @NSGC_CancerSIG

Great collaboration with #JohnChan @SutterHealth using @myriadgenetics registry data! Rates of germline mutations in uterine cancer were high (14.6%) & varied by ancestry. This large database of >35k pts verified our @TeamEndo_MSK data. sciencedirect.com/science/articl…

MUTYH: Possibly another important gene in ovarian cancer? sciencedirect.com/science/articl…. Studies are small and more work needs to be done. Thanks #melissafrey for letting me join this work! @TeamOvary_MSK

Thanks #ProfMichaelSeckl from @imperialcollege & #charingcross who shared his expertise on #gestationaltrophoblasticneoplasm (GTN) and the promise of immunotherapy! #raretumors @TeamOvary_MSK @TeamEndo_MSK @MSKCancerCenter @MSK_DeptOfMed

Our amazing fellow #clarissalam looked at role of pre-operative imaging in #endometrialcancer and found that symptoms/physical exam were critical in low grade EC but that imaging found disease in asymptomatic patients with high grade EC @TeamEndo_MSK

My amazing colleague #RachelGrisham bringing novel therapies to rare cancer types! Avutometinib + Defactinib shows promise in mesonephric tumors and is moving to 2nd stage. Great moderating by @ROCearbhaill #SGO2025. @TeamOvary_MSK @TeamEndo_MSK @MSK_DeptOfMed @MSKCancerCenter

Exciting data presented by @BakkumGamez for a novel tampon-based screening test for #EndometrialCancer! Could have implications for those at high genetic risk and #lynchsyndrome @CGAIGC @TeamEndo_MSK

Dr Chinmayi A showing data from @myriadgenetics on ancestry-based differences in VUS findings in >80k patients with #ovariancancer. We need to include more diverse women in genetic testing and only make recs for pathogenic variants! #SGO2025 @TeamOvary_MSK @SutterHealth @aboutKP